{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:33:32Z","timestamp":1787502812109,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11655-025-4023-6","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:32:50Z","timestamp":1760923970000},"page":"73-79","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of Xueshuantong Injection in Reducing Residual Inflammatory Risk in Unstable Angina Patients: A Randomized Double-Blind Controlled Trial"],"prefix":"10.1007","volume":"32","author":[{"given":"Ya-xing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-kai","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-ye","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-ming","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"key":"4023_CR1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020;396:1204\u20131222.","journal-title":"Lancet"},{"key":"4023_CR2","doi-asserted-by":"publisher","first-page":"e079197","DOI":"10.1136\/bmj-2024-079197","volume":"387","author":"J Lu","year":"2024","unstructured":"Lu J, Xu Y, Bi Y, Wang T, Zheng R, Wang W, et al. Reducing inequity through tackling social determinants of cardiovascular diseases in China. BMJ 2024;387:e079197.","journal-title":"BMJ"},{"key":"4023_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1056\/NEJM200001133420207","volume":"342","author":"Y Yeghiazarians","year":"2000","unstructured":"Yeghiazarians Y, Braunstein J, Askari A, PH Stone. Unstable angina pectoris. N Engl J Med 2000;342:101\u2013114.","journal-title":"N Engl J Med"},{"key":"4023_CR4","first-page":"187","volume":"13","author":"B Ibanez","year":"2024","unstructured":"Ibanez B, Byrne R. ACS encompasses a spectrum-unstable angina, NSTEMI, and STEMI. Eur Heart J Acute Cardiovasc Care 2024;13:187.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"4023_CR5","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s00392-024-02471-w","volume":"114","author":"B Bay","year":"2025","unstructured":"Bay B, Vogel B, Sharma R, Sartori S, Leone P, Nathani M, et al. Inflammatory risk and clinical outcomes according to polyvascular atherosclerotic disease status in patients undergoing PCI. Clin Res Cardiol 2025;114:969\u2013977.","journal-title":"Clin Res Cardiol"},{"key":"4023_CR6","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","volume":"376","author":"C Baigent","year":"2010","unstructured":"Cholesterol Treatment Trialists\u2019 (CTT) Collaboration, Baigent C, Blackwell L, Holland L, Reith C, Bhala N, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010;376:1670\u20131681.","journal-title":"Lancet"},{"key":"4023_CR7","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1001\/jama.2020.22258","volume":"324","author":"S Nicholls","year":"2020","unstructured":"Nicholls S, Lincoff A, Garcia M, Bash D, Ballantyne C, Barter P, et al. Effect of high-dose omega-3 fatty acids vs. corn oil on major adverse crdiovascular events in patients at high cardiovascular risk: the strength randomized clinical trial. JAMA 2020;324:2268\u20132280.","journal-title":"JAMA"},{"key":"4023_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1812792","volume":"380","author":"D Bhatt","year":"2019","unstructured":"Bhatt D, Steg P, Miller M, Brinton E, Jacobson T, Ketchum S, et al. Cardiovascular risk reduction with Icosapent ethyl for hypertriglyceridemia. N Engl J Med 2019;380:11\u201322.","journal-title":"N Engl J Med"},{"key":"4023_CR9","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1056\/NEJMoa2210645","volume":"387","author":"A Pradhan","year":"2022","unstructured":"Pradhan A, Glynn R, Fruchart J, MacFadyen J, Zaharris E, Everett B, et al. Triglyceride lowering with pemafibrate to reduce cardiovascular risk. N Engl J Med 2022;387:1923\u20131934.","journal-title":"N Engl J Med"},{"key":"4023_CR10","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.jacc.2019.01.077","volume":"73","author":"P Guedeney","year":"2019","unstructured":"Guedeney P, Claessen B, Kalkman D, Aquino M, Sorrentino S, Giustino G, et al. Residual inflammatory risk in patients with low LDL cholesterol levels undergoing percutaneous coronary intervention. J Am Coll Cardiol 2019;73:2401\u20132409.","journal-title":"J Am Coll Cardiol"},{"key":"4023_CR11","doi-asserted-by":"publisher","first-page":"116156","DOI":"10.1016\/j.jep.2023.116156","volume":"307","author":"Y Xie","year":"2023","unstructured":"Xie Y, Wang C. Herb-drug interactions between Panax notoginseng or its biologically active compounds and therapeutic drugs: a comprehensive pharmacodynamic and pharmacokinetic review. J Ethnopharmacol 2023;307:116156.","journal-title":"J Ethnopharmacol"},{"key":"4023_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s11011-016-9901-3","volume":"32","author":"X Shi","year":"2017","unstructured":"Shi X, Yu W, Liu L, Liu W, Zhang X, Yang T, et al. Panax notoginseng saponins administration modulates pro-\/anti-inflammatory factor expression and improves neurologic outcome following permanent MCAO in rats. Metab Brain Dis 2017;32:221\u2013233.","journal-title":"Metab Brain Dis"},{"key":"4023_CR13","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.3390\/nu16132120","volume":"16","author":"C Mancuso","year":"2024","unstructured":"Mancuso C. Panax notoginseng: pharmacological aspects and toxicological issues. Nutrients 2024;16:2120.","journal-title":"Nutrients"},{"key":"4023_CR14","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s11655-023-3638-8","volume":"29","author":"XY Ren","year":"2023","unstructured":"Ren XY, Li YF, Liu HQ, Lin H, Lin Q, Wu Y, et al. Anti-inflammatory therapy progress in major adverse cardiac events after PCI: Chinese and Western medicine. Chin J Integr Med 2023;29:655\u2013664.","journal-title":"Chin J Integr Med"},{"key":"4023_CR15","doi-asserted-by":"publisher","first-page":"e081123","DOI":"10.1136\/bmj-2024-081123","volume":"388","author":"S Hopewell","year":"2025","unstructured":"Hopewell S, Chan A, Collins G, Hr\u00f3bjartsson A, Moher D, Schulz K, et al. CONSORT 2025 Statement: updated guideline for reporting randomised trials. BMJ 2025;388:e081123.","journal-title":"BMJ"},{"key":"4023_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/jama.2024.21972","volume":"333","author":"World Medical Association","year":"2025","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human participants. JAMA 2025;333:71\u201374.","journal-title":"JAMA"},{"key":"4023_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"J Knuuti","year":"2020","unstructured":"Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020;41:407\u2013477.","journal-title":"Eur Heart J"},{"key":"4023_CR18","first-page":"539","volume":"59","author":"J Wang","year":"2018","unstructured":"Wang J, Xing YW. Diagnostic criteria for elements of evidence of angina pectoris in coronary heart disease. J Tradit Chin Med (Chin) 2018;59:539\u2013540.","journal-title":"J Tradit Chin Med (Chin)"},{"issue":"18","key":"4023_CR19","first-page":"50","volume":"16","author":"YH Wang","year":"2019","unstructured":"Wang YH. Effect of injectable thromboxane on inflammatory factors and prognosis of patients with acute cerebral infarction. China Med Innov (Chin) 2019;16(18):50\u201354.","journal-title":"China Med Innov (Chin)"},{"key":"4023_CR20","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1093\/eurheartj\/ehaf196","volume":"46","author":"B Bay","year":"2025","unstructured":"Bay B, Tanner R, Gao M, Oliva A, Sartori S, Vogel B, et al. Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary intervention. Eur Heart J 2025;46:3167\u20133177.","journal-title":"Eur Heart J"},{"key":"4023_CR21","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","volume":"401","author":"P Ridker","year":"2023","unstructured":"Ridker P, Bhatt D, Pradhan A, Glynn R, MacFadyen J, Nissen S, et al. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials. Lancet 2023;401:1293\u20131301.","journal-title":"Lancet"},{"key":"4023_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11883-024-01259-7","volume":"27","author":"N Mehta","year":"2024","unstructured":"Mehta N, deGoma E, Shapiro M. IL-6 and cardiovascular risk: a narrative review. Curr Atheroscler Rep 2024;27:12.","journal-title":"Curr Atheroscler Rep"},{"key":"4023_CR23","first-page":"389","volume":"16","author":"M B\u00e4ck","year":"2019","unstructured":"B\u00e4ck M, Yurdagul A, Tabas I, \u00d6\u00f6rni K, Kovanen P. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Rev Cardiol 2019;16:389\u2013406.","journal-title":"Nat Rev Cardiol"},{"key":"4023_CR24","first-page":"2525","volume":"117","author":"P Libby","year":"2021","unstructured":"Libby P. Inflammation during the life cycle of the atherosclerotic plaque. Cardiovasc Res 2021;117:2525\u20132536.","journal-title":"Cardiovasc Res"},{"key":"4023_CR25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/MOL.0000000000000843","volume":"33","author":"C Scipione","year":"2022","unstructured":"Scipione C, Cybulsky M. Early atherogenesis: new insights from new approaches. Curr Opin Lipidol 2022;33:271\u2013276.","journal-title":"Curr Opin Lipidol"},{"key":"4023_CR26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1152\/physiol.00029.2013","volume":"28","author":"A Yabluchanskiy","year":"2013","unstructured":"Yabluchanskiy A, Ma Y, Iyer R, Hall M, Lindsey M. Matrix metalloproteinase-9: many shades of function in cardiovascular disease. Physiology 2013;28:391\u2013403.","journal-title":"Physiology"},{"key":"4023_CR27","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1161\/CIRCRESAHA.117.312200","volume":"121","author":"B Iba\u00f1ez","year":"2017","unstructured":"Iba\u00f1ez B, Fuster V. Cantos: a gigantic proof-of-concept trial. Circ Res 2017;121:1320\u20131322.","journal-title":"Circ Res"},{"key":"4023_CR28","first-page":"1707","volume":"14","author":"Y Dong","year":"2019","unstructured":"Dong Y, Feng LL, Liu YM, Wang J. Network pharmacology-based study on the target of action of total saponins of Panax ginseng in the treatment of coronary heart disease. World J Integr Med 2019;14:1707\u20131711, 1723.","journal-title":"World J Integr Med"},{"key":"4023_CR29","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jep.2016.09.022","volume":"192","author":"J Fan","year":"2016","unstructured":"Fan J, Liu D, He C, Li X, He F. Inhibiting adhesion events by Panax notoginseng saponins and ginsenoside Rb1 protecting arteries via activation of Nrf2 and suppression of p38-VCAM-1 signal pathway. J Ethnopharmacol 2016;192:423\u2013430.","journal-title":"J Ethnopharmacol"},{"key":"4023_CR30","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1142\/S0192415X24500332","volume":"52","author":"LL Wang","year":"2024","unstructured":"Wang LL, Kang ML, Liu CW, Liu L, Tang B. Panax notoginseng saponins activate nuclear factor erythroid 2-related factor 2 to inhibit ferroptosis and attenuate inflammatory injury in cerebral ischemia-reperfusion. Am J Chin Med 2024;52:821\u2013839.","journal-title":"Am J Chin Med"},{"key":"4023_CR31","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s11655-020-3088-5","volume":"26","author":"RL Li","year":"2020","unstructured":"Li RL, Wang JX, Chai LJ, Guo H, Wang H, Chen L, et al. Xueshuantong Injection (Lyophilized) alleviates streptozotocin-induced diabetic retinopathy in rats. Chin J Integr Med 2020;26:825\u2013832.","journal-title":"Chin J Integr Med"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-025-4023-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-025-4023-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-025-4023-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T22:01:29Z","timestamp":1767823289000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-025-4023-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4023"],"URL":"https:\/\/doi.org\/10.1007\/s11655-025-4023-6","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"assertion":[{"value":"11 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There is no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}